[1]
“Bioanalytical Method Development and Validation for Empagliflozin and Semaglutide: A Comparative Review”, JOC, vol. 24, no. 4s, pp. 905–913, Sep. 2025, doi: 10.64149/J.Carcinog.24.4s.905-913.